Cutler Group’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,239
Closed 5019
2022
Q4
$0 Sell
5,239
-300
-5% -$43 ﹤0.01% 5526
2022
Q3
$0 Sell
5,539
-10,806
-66% -$5.82K ﹤0.01% 5752
2022
Q2
$28K Sell
16,345
-134,613
-89% -$302K ﹤0.01% 2422
2022
Q1
$454K Buy
150,958
+134,627
+824% +$360K 0.02% 721
2021
Q4
$60K Buy
16,331
+11,126
+214% +$65.1K ﹤0.01% 2261
2021
Q3
$30K Buy
5,205
+694
+15% +$9.75K ﹤0.01% 2979
2021
Q2
$78K Sell
4,511
-2,889
-39% -$52.7K ﹤0.01% 2095
2021
Q1
$141K Buy
+7,400
New +$135K 0.01% 1513

Other funds holding HGEN

Cutler Group's HGEN Position: Q1 2023 in Review

Cutler Group sold out of HUMANIGEN, INC. (HGEN) in Q1 2023, closing a stake of 5,239 shares.

Cutler Group first reported a position in HGEN in Q1 2021 and held it in 8 quarters. The position peaked at $454K in Q1 2022. 42 funds tracked by Wall St. Rank hold HGEN as of Q1 2023.

  • Cutler Group reported no remaining HUMANIGEN, INC. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 5,239 HUMANIGEN, INC. shares in Q1 2023.
  • Cutler Group first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 8 quarters.
  • Cutler Group's HUMANIGEN, INC. position peaked at $454K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.